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Abstract
Purpose: Transurethral ultrasound therapy is an investigational treatment
modality which could potentially be used for the localised treatment of
prostate cancer. One of the limiting factors of this therapy is prostatic calci-
fications. These attenuate and reflect ultrasound and thus reduce the efficacy
of the heating. The aim of this study is to investigate how prostatic calcifica-
tions affect therapeutic efficacy, and to identify the best sonication strategy
when calcifications are present. Methods: Realistic computational models
were used on clinical patient data in order to simulate different therapeutic
situations with naturally occurring calcifications as well as artificial calcifi-
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cations of different sizes (1-10 mm) and distances (5-15 mm). Furthermore,
different sonication strategies were tested in order to deliver therapy to the
untreated tissue regions behind the calcifications. Results: The presence of
calcifications in front of the ultrasound field was found to increase the peak
pressure by 100% on average while the maximum temperature only rose by
9% during a 20-second sonication. Losses in ultrasound energy were due to
the relative large acoustic impedance mismatch between the prostate tissue
and the calcifications (1.63 vs. 3.20 MRayl) and high attenuation coefficient
(0.78 vs. 2.64 dB/MHz1.1/cm), which together left untreated tissue regions
behind the calcifications. In addition, elevated temperatures were seen in
the region between the transducer and the calcifications. Lower sonication
frequencies (1-4 MHz) were not able to penetrate through the calcifications
effectively, but longer sonication durations (20-60 s) with selective transducer
elements were effective in treating the tissue regions behind the calcifica-
tions. Conclusions: Prostatic calcifications limit the reach of therapeutic
ultrasound treatment due to reflections and attenuation. The tissue regions
behind the calcifications can possibly be treated using longer sonication dura-
tions combined with proper transducer element selection. However, caution
should taken with calcifications located close to sensitive organs such as the
urethra, bladder neck or rectal wall.
c© 2018 Wiley.
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Introduction
Prostate cancer is the second most common cancer occurring in men with
an estimated 1.1 million people diagnosed worldwide in 2012 (Stewart and
Wild, 2014). In the same year, approximately 0.3 million people died due to
the disease making prostate cancer the fifth most common cause of cancer
death among men. To put these figures into perspective, prostate cancer
accounts for approximately 15% of all cancer incidences and 7% of all cancer
related deaths in men (Stewart and Wild, 2014). The incidence of prostate
cancer increases drastically with age (Zhou et al., 2016), with the vast ma-
jority (99%) of cases diagnosed in men over 50 years old (Stewart and Wild,
2014). Patients with prostate cancer may experience non-specific local symp-
toms as urinary problems or symptoms resulting from distant metastasised
disease as bone pain. Prostate cancer may progress locally to adjacent tissues
and/or metastasise to other parts of the body including regional and non-
regional lymph nodes, bone and extra-nodal soft tissues (Bubendorf et al.,
2000). Therefore, early diagnosis and effective treatment of the disease are
essential for the well-being and survival of the patients.
Typically, clinically significant localised prostate cancer is treated with
curative intended therapies such as radical prostatectomy or radiotherapy.
These can improve prognosis and survival with or without a multimodal
approach depending on disease characteristics. However, they both involve
treatment related toxicity that may worsen the outcome of bowel and gen-
itourinary function, possibly impairing quality of life (Fowler et al., 1993;
Talcott et al., 1998). Therefore, patients would greatly benefit from a treat-
ment option which offers similar therapeutic result with minimal side effects
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and low risk of post-operative complications.
Therapeutic ultrasound for the treatment of localised prostate cancer has
been studied for over two decades (Madersbacher et al., 1995) and the clinical
results have been promising (Chaussy and Thu¨roff, 2001; Thu¨roff et al., 2003;
Uchida et al., 2006). There are no severe side effects from ultrasound if
applied appropriately and the treatment can be repeated because there is
no cumulative dose limit (Chaussy and Thu¨roff, 2001; Poissonnier et al.,
2007). Furthermore, unlike chemotherapy, ultrasound therapy can be used to
treat any tumour cell types that are susceptible to high temperatures, which
makes it an effective therapy method for multiple cancer types (Sapareto
and Dewey, 1984). Therapeutic ultrasound could thus become the primary
treatment of localised prostate cancer for selected patients, which offers a
minimally invasive alternative for the traditional methods. The treatment
has been cleared for clinical use in Europe, Asia and North America, and is
currently in use in several hospitals and clinics.
Therapeutic ultrasound treatment of the prostate can be conducted us-
ing either a transrectal or transurethral route (Uchida et al., 2006; Chin
et al., 2016). This study focuses on transurethral ultrasound therapy, but
the results can also be generalised to the transrectal treatment of prostate
cancer. The treatment is conducted by first inserting the therapeutic ul-
trasound probe through the urethra and positioning it near the target. An
endorectal cooling device is also used during the therapy in order to prevent
the heating and destruction of neighbouring healthy tissues. Once ready, the
ultrasound transducer elements in the probe are activated to deliver acoustic
energy to the prostate which is absorbed by the tissue creating heat (Chopra
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et al., 2009; Siddiqui et al., 2010). The probe is automatically rotated in
order to ablate the entire tumour volume and magnetic resonance imaging
(MRI) is used to monitor and control the heating (Diederich et al., 2004;
Sammet et al., 2015).
The initial clinical evidence from transurethral prostate treatments has
shown variability in efficacy (Chin et al., 2016; Ramsay et al., 2017), which
could be due to several factors. One factor might be naturally occurring
prostatic calcifications (Suh et al., 2008) which can obstruct the penetration
of the therapeutic ultrasound field and thus reduce the efficacy of the treat-
ment. The prevalence of prostatic calcifications varies widely from 7% to
70% depending on the patient group, and their occurrence and size increases
with age (Hyun, 2018). Prostatic calcifications are usually classified as be-
ing of primary/endogenous type or of secondary/extrinsic type. Endogenous
calcifications are thought to be caused by the obstruction of the prostatic
ducts around the enlarged prostate by benign prostatic hyperplasia (BPH)
or by chronic inflammation. Extrinsic calcifications are caused by urine re-
flux and thus typically occur around the urethra (Hyun, 2018). Prostatic
calcifications can occur alone or in aggregates, and their sizes can reach from
0.5 mm to greater than 15 mm (Hong et al., 2012; Hyun, 2018).
The mechanical and acoustic properties of calcifications differ from those
of the prostate tissue, which could potentially cause strong reflections of
the ultrasound field. Furthermore, the irregular shape and location of cal-
cifications can deform the ultrasound field making the predictability of the
treatment difficult. This effect is further increased by the local aggregation of
several calcifications. All these effects can reduce the efficiency of ultrasound
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therapy in the prostate. For the patient, this means either longer therapy
times, or in the worst case, termination of the treatment. Either case results
in inconveniences for both the patient and clinical personnel. The aim of this
research is therefore to find out how much the efficacy of ultrasound ther-
apy in the prostate is affected by the scenarios described above. The study
is conducted by using both naturally occurring calcifications in segmented
computed tomography (CT) patient data as well as artificial calcifications
with pre-defined dimensions and locations. The results can be applied to the
treatment planning stage in order to improve therapeutic outcomes and to
define patient selection criteria for the treatments.
Treatment simulations
Study protocol
Whilst it is difficult, if not impossible, to quantify the effects of cal-
cifications in vivo in the prostate, it is possible to replicate their effects
using three-dimensional clinical imaging data from patients together with
suitable computational models. Hence, the research was carried out using
both acoustic and thermal simulation models together with segmented clini-
cal CT data (Optima CT660, GE Healthcare, Chicago, IL, USA / Somatom
go.Up, Siemens Healthineers, Erlangen, Germany) from three patients. The
patient data were acquired during ultrasound therapy treatments at Turku
University Hospital, Finland, using a Tulsa-Pro ultrasound system (Profound
Medical Corp, Toronto, Canada). The ultrasound probe of the system has 10
unfocused elements (element size 5 mm × 4.5 mm with zero spacing) giving a
total transducer surface area of 50 mm × 4.5 mm. The transducer is located
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2 mm inside the ultrasound probe which contains a layer of cooling water in
front of it. The patients were selected for the simulation study if prostatic
calcifications were identified in their CT images. Ethical permission for the
study (ETMK: 152/1801/2016) was obtained from the Ethics Committee of
Hospital District of Southwest Finland.
The study comprises of three parts. In the first part, data for three differ-
ent prostate cancer patients are presented. The simulation data comprised of
segmented CT volumes of the prostate in each patient. The original resolu-
tion of the CT images was 0.97 and 0.95 mm with a slice thicknesses of 1.25
and 1.00 mm for the GE and Siemens CT scanners, respectively. After 3-D
interpolation, the grid resolution was set to 0.0462 mm. A visualisation of
the simulation geometry is presented in Figure 1. Each patient was sonicated
using the transurethral ultrasound device (Tulsa-Pro) for 20 seconds followed
by a 40-second cooling time. The transducer was operated at 4 MHz and a
Figure 1: The ultrasound probe (brass) was positioned along the urethra in the middle of
the prostate (magenta) so that the transducer (cyan) was facing the calcifications (black).
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constant power level was used. The position of the transducer was kept con-
stant throughout the sonication (i.e., no rotation) so that it was facing the
calcifications. The results compare the acoustic pressure parameters as well
as the evolution of temperature and thermal dose in each individual patient.
In the second part of the study, artificial calcifications of different sizes and
locations were placed in the prostate of the same patient in order to examine
their effect on therapeutic efficacy. In each case, the artificial calcification
had a spherical shape, with its diameter varied between 1-10 mm and its
location (the centre point) from the transducer face varied between 5-15 mm.
Different sonication durations (10-40 s) and frequencies (1-4 MHz) with a
fixed calcification diameter (5 mm) and location (10 mm) were also used to
study their effect on the measured parameters. The same power level was
used in all cases.
In the third part of the study, different sonication strategies were tested
using clinical patient data in order to treat the tissue region behind the
calcification. The number of active elements and the sonication durations
of individual elements were changed in order to ablate the target region.
The best strategy to treat the tissue region behind the calcification was then
suggested based on the results.
Acoustic simulation parameters and execution
A more detailed description of the acoustic simulation model can be found
from a previous study (Suomi et al., 2018), but it is shortly described here.
The ultrasound simulations were carried out using the parallelised C++ ver-
sion of the open source k-Wave Toolbox (Treeby et al., 2012; Jaros et al.,
2016). The code solves a set of three coupled first-order partial differen-
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tial equations. These are based on the conservation of mass, conservation
of momentum, and a pressure-density relation that includes a phenomeno-
logical loss term accounting for acoustic absorption that follows a frequency
power law. The governing equations are equivalent to a generalised version of
the Westervelt equation that accounts for second-order acoustic nonlinearity,
power law acoustic absorption, and a heterogeneous distribution of material
properties (sound speed, density, nonlinearity and absorption coefficient).
The ultrasound simulations were run on a computing cluster at CSC - IT
Centre for Science, Finland, using 384 cores (Haswell / Sandy bridge, Intel,
Santa Clara, CA, USA), up to 150 GB memory and approximately 4 hours
per simulation. Several convergence studies were run prior the study in
order to define the optimal grid size and temporal resolution for accuracy and
computational speed. The sizes of the computational grids were at maximum
1152 × 1536 × 384 grid points, i.e., 5.3 cm × 7.1 cm × 1.8 cm, and they
supported harmonic frequencies up to 16 MHz (i.e., four harmonics with the
sonication frequency of 4 MHz). The temporal resolution was set to 30 points
per period (at 4 MHz) which corresponded to a time step of 8.3 ns. The last
three cycles of the time domain waveforms were saved over the whole grid
for data analysis.
The acoustic properties of tissues used in the simulations are presented
in Table 1 (Mast, 2000; Hasgall et al., 2015; Parker et al., 1993). Since
the acoustic properties of prostatic calcifications are not characterised in the
literature, they were defined based on materials whose chemical composi-
tion is similar. Renal stones consist mainly of calcium oxalate (Manglaviti
et al., 2011) which is also one of the main components of prostatic calcifica-
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Table 1: Acoustic simulation parameters (Mast, 2000; Hasgall et al., 2015; Parker et al.,
1993)
Density Sound speed Attenuation B/A
(kg/m3) (m/s) (dB/MHz1.1/cm)
Prostate 1045 1561 0.78 7.5
Calcification 1466 2184 2.64 7.5
Muscle 1050 1547 1.09 7.2
Fat 950 1478 0.48 10.1
Water 1000 1520 0.00217 5.2
tions (Sfanos et al., 2009; Dessombz et al., 2012). Therefore, it is reasonable
to define the acoustic properties of prostatic calcifications as those of renal
stones (Singh and Agarwal, 1989). Due to the large variation in the measured
values, the average value for each property was used. If the variation is a
result of natural differences in the calcifications rather than measurement in-
accuracy, this could possibly create local changes to the acoustic field within
the calcifications in the simulations.
Thermal simulation parameters and execution
The thermal simulations were conducted using the k-Wave Toolbox. This
solves Pennes bioheat transfer equation using a non-standard pseudospectral
method (Treeby et al., 2017). The model is exact in the case of homogeneous
media, and gives high accuracy for low computational cost in the case of
heterogeneous material parameters. The model accounts for heat diffusion,
advective heat loss due to tissue perfusion and heat deposition due to nonlin-
ear ultrasound absorption. The solution took into account the specific heat
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capacity, thermal conductivity and the perfusion in different tissues. The
heating rate was calculated using the harmonic components of the nonlinear
ultrasound field. This was done in order to accurately replicate the increased
heating effect of the ultrasound field due to nonlinearity.
The thermal simulations were run in Matlab R2017a (MathWorks, Nat-
ick, Massachusetts, United States) on same cluster as the acoustic simula-
tions with approximately 4 hours per simulation. The grid resolution was
decimated by a factor of 4 (with respect to ultrasound simulations) for com-
putational efficiency and a time step of 20 ms was used. The temperature of
the water inside the ultrasound probe was held constant at 21 ◦C to mimic
the cooling effect of the room temperature water flowing through the clinical
system. The perfusion rate was set to zero for tissue regions which reached
a thermal dose of 240 cumulative equivalent minutes at 43 ◦C (CEM).
The thermal simulations were conducted using the tissue parameters in
Table 2 (van Vulpen et al., 2002; Patch et al., 2011; Hasgall et al., 2015). The
thermal properties of prostatic calcifications are likewise not characterised in
the literature, and thus the thermal properties of calcium carbonate were
used (Ramachandran et al., 2006). Calcium carbonate crystals promote cal-
cium oxalate crystallisation by heterogeneous or epitaxial nucleation (Geider
et al., 1996), which is why it is often found in prostatic calcifications alongside
with calcium oxalate (Sfanos et al., 2009; Dessombz et al., 2012).
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Table 2: Thermal simulation parameters (van Vulpen et al., 2002; Patch et al., 2011;
Hasgall et al., 2015)
Thermal Specific Perfusion
conductivity heat capacity rate
(W/m/K) (J/kg/K) (kg/m3/s)
Prostate 0.51 3400 1.7
Calcification 3.85 858 0
Muscle 0.49 3421 0.6
Fat 0.21 2348 0.6
Water 0.60 4178 0
Blood N/A 3617 N/A
Results
Study with natural calcifications
Figure 2(a) shows an axial slice of the segmented CT data from patient
1 along the centre of the transducer (the x-axis represents the craniocau-
dal direction). The tissue regions in the image are prostate (grey), muscle
(light grey), fat (black) and calcifications (white). Figure 2(b) shows the
same CT slice together with the simulated ultrasound field. The peak pres-
sure of the ultrasound field in this case was 2.1 MPa which was located in
front of the large calcification at x = 15 mm, y = 7 mm. The calcifications
cause strong reflection and attenuation of the ultrasound field. This means
very little acoustic energy reaches the regions behind the calcifications. The
strong reflections are created by the large acoustic impedance differences be-
tween the prostate tissue and the calcifications (1.63 vs. 3.20 MRayl), which
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causes approximately 10.6% of the incident energy to be reflected at the
interface. In addition, the incident ultrasound energy is further decreased
inside the calcifications due to their high attenuation coefficient (0.78 vs.
2.64 dB/MHz1.1/cm).
Figure 2(c) shows the temperature field on top of the CT slice at the end
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Figure 2: Segmented computed tomography (CT) slice of the half of the prostate (grey)
with calcifications (white) in patient 1. The tissue regions surrounding the prostate were
segmented as fat (black) and muscle (light grey). The ultrasound probe was positioned
along the urethra in the middle of the prostate (i.e., on the top of the image). Simulated
(b) ultrasound, (c) temperature and (d) 240 cumulative equivalent minutes (CEM) thermal
dose fields at the end of the sonication.
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of a 20-second sonication. The peak temperature at the end of the sonication
was 79.8 ◦C which was located at x = 15 mm, y = 5 mm. Again, it can be seen
that the temperature does not increase drastically behind the calcifications
apart from the regions located in close proximity to the calcifications. On
the contrary, the temperature inside the calcifications rises faster than the
rest of the prostate tissue due to their relatively low specific heat capacity
(3400 vs. 858 J/kg/K) and lack of perfusion. However, this thermal energy
is also dissipated away quickly due to the high thermal conductivity (0.51 vs.
3.85 W/m/K). This causes the tissue regions surrounding the calcifications to
absorb some of the thermal energy. Figure 2(d) shows the 240 CEM thermal
dose field after the 20-second sonication followed by a 40-second cooling time.
The thermal damage to the tissue regions behind the calcifications does not
extend as far as in the regions where there are no calcifications in the way
of the ultrasound field. Only the tissues which are in direct contact with
calcifications have absorbed enough thermal energy to induce damage. Some
thermal damage has also been induced to the tissues outside the prostate on
the right-hand side of the figure.
The temperature evolution at 5 mm from the centre of the transducer (the
origin) in all patients is presented in Figure 3(a). The temperature profiles at
these locations are in the prostate tissue (i.e., not inside the calcifications).
It is evident from the figure there are no drastic differences between the
three patients, with the temperatures reaching a maximum of approximately
73 ◦C in each case after the 20-second sonication. In the clinical setting, a
minimum temperature of 55 ◦C is desired inside the treatment region. The
axial temperature profiles (along the y-axis) from the centre of the transducer
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are shown in Figure 3(b). The temperature inside the transducer was kept
constant at 21 ◦C, which is shown as a horizontal line along the first 2 mm
from the transducer. Again, big differences are not seen between different
patients, with temperatures peaking approximately at y = 5.4 mm. After
the peak, the temperature curves decrease steadily towards the outer edge of
the prostate where steeper drops are seen.
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Figure 3: (a) Temperature evolution measured at a distance of 5 mm from the centre of
the transducer during a 20-second sonication followed by a 40-second cooling time in three
patients. (b) Axial temperature profiles at the end of the 20-second sonication along the
y-axis from the centre of the transducer (the origin). The ultrasound probe was held at
a constant temperature of 21 ◦C. (c) Evolution of the temperature inside the calcification
with respect to the prostate tissue at the same distance from the transducer in patient 2.
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Figure 3(c) shows the temperature evolution inside the calcification with
respect to the prostate tissue at the same distance in patient 2. It can be
seen that the temperature rises faster inside the calcification due to the lower
specific heat capacity but also dissipates faster after the sonication due to
the higher thermal conductivity. This happens despite the fact that there is
no perfusion in the calcification.
A close up cutout of the distortion of the ultrasound field (thresholded at
−10 dB) in the presence of a calcification is shown in Figure 4(a) in patient
2. A strong pressure region is formed in front of the calcification which is
also partly penetrates inside. As mentioned earlier, the strong reflections
are caused by the large acoustic impedance differences between the prostate
and the calcifications. The ultrasound energy is further attenuated inside
the calcification due to its high attenuation coefficient and then reflected
again when entering the prostate from the back side. The temperature and
thermal dose field cutouts during the 20-second sonication are presented in
Figures 4(b)-(c), respectively. The temperature and thermal dose fields start
to evolve first in the vicinity of the calcification where the strongest pressure
regions are located. The heating rate is directly related to the intensity of the
ultrasound field which shows as high temperature and thermal dose values in
the same locations. The high thermal conductivity of the calcification also
dissipates heat energy to the tissue regions surrounding the calcification.
Comparison of the maximum acoustic pressures, temperatures and ther-
mal dose volumes in all patients are shown in Figures 5(a)-(c), respectively.
The maximum pressures in the presence of calcifications are two-fold (99.9%
higher on average) compared to the simulations without calcifications. As
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Figure 4: Three-dimensional visualisation of (a) the acoustic pressure field (thresholded
at −10 dB) and the evolution of (b) temperature (thresholded at 75 ◦C) and (c) thermal
dose (thresholded at 1.5×108 CEM) fields in the presence of a calcification (black) inside
the prostate during a 20-second sonication in patient 2.
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mentioned earlier, the high pressures are caused by the large acoustic impedance
differences between the calcification and the prostate tissue, which causes
the ultrasound field to strongly reflect at the interface causing the accumula-
tion of the acoustic pressure. The temperatures in the presence of calcifica-
tions are only slightly (9.1% on average) higher when compared to the same
prostate without calcifications. Although the regions with calcifications tend
to heat up faster due to the presence of high pressure regions as well as their
relatively low specific heat capacity, they also conduct the heat away quickly
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Figure 5: Comparison of (a) maximum acoustic pressures, (b) maximum temperatures and
(c) 240 CEM thermal dose volumes in three different patients with and without naturally
occurring calcifications. The sonication duration was 20 seconds followed by a 40-second
cooling time.
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to the neighbouring tissues. This also causes the tissue regions surrounding
the calcifications to rise in temperature.
Perhaps surprisingly, the thermal dose volumes in the presence of calcifi-
cations are slightly higher than when sonicating the same duration without
calcifications. This is due to the geometry of the simulations: the simulations
were conducted with a fixed transducer position (i.e., no rotation), and hence
the regions ‘below’ and ‘above’ the calcifications obtained some thermal dam-
age due to thermal conduction. This caused the thermal dose volume to grow
in the elevation direction (i.e., the z-axis). Without calcifications, the ther-
mal dose volumes in the elevation direction are smaller. In a real treatment
situation, however, the rotational movement of the ultrasound probe would
treat the regions below and above the calcifications. The results between
different patients cannot be directly compared due their different prostate
sizes as well as different sizes and locations of the calcifications.
Study with artificial calcifications
The study with artificial calcifications was conducted by using spherical
calcifications of different sizes and locations inside the prostate. Further-
more, different sonication durations and frequencies were used in order to
examine their effect on the temperature evolution and thermal dose areas.
The thermal dose areas were quantified instead of the volumes, because only
the area is clinically significant due to the rotational movement of the trans-
ducer. The volume surrounding the calcification in the z-direction (elevation)
will be ablated by the rotation of the transducer regardless of the presence of
a calcification. The simulation geometry with a 5 mm diameter calcification
located at 10 mm distance from the centre of the transducer is shown in
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Figure 6(a) together with simulated (b) ultrasound, (c) temperature and (d)
240 CEM thermal dose fields.
Figure 7(a) shows the evolution of the thermal dose area when the di-
ameter of the spherical calcification was changed while its central distance
from the transducer was kept constant at 10 mm. In Figure 7(e), the same
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Figure 6: Segmented computed tomography (CT) slice of the half of the prostate (grey)
with an artificial spherical calcification (white). The tissue areas surrounding the prostate
were segmented as fat (black) and muscle (light grey). The calcification had a diameter of
5 mm and its centre was located 10 mm from the transducer along y-axis. Simulated (b)
ultrasound, (c) temperature and (d) 240 cumulative equivalent minutes (CEM) thermal
dose fields at the end of the sonication.
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areas are shown with 2-D contours on the axial plane cutting the centre of
the transducer. The thermal dose areas reduce with the diameter of the
calcification up to 5 mm after which the area starts to grow again. This is
because at this point the diameter of the calcification becomes so large that
the thermal damage extends beyond the areas of smaller calcifications.
Figure 7(b) shows the dependence of thermal dose area upon the distance
of the central point of the calcification from the centre of the transducer while
the diameter was kept constant at 5 mm. Figure 7(f) shows the thermal dose
area boundaries on the axial plane. It should be noted that the distance of
the outer surface of the calcification in Figure 7 is actually 2.5 mm closer than
the indicated central point. This means that the outer surface of the nearest
calcification in the figure is actually only 2.5 mm away from the transducer
and 0.5 mm away from the ultrasound probe.
In Figure 7(b), the thermal dose area grows as the distance of the calci-
fication from the transducer becomes larger. There exists an almost linear
dependence of the thermal dose area on the distance. This is somewhat
expected because the calcification almost completely blocks the ultrasound
field from penetrating to the rear region thus diminishing the heating effect.
The closer the calcification is located to the transducer, the larger the re-
gion behind it that remains untreated. When the calcification is located very
close to the transducer, some thermal damage is induced to the tissue near
the urethra (see the upper blue and red boundaries in Figure 7(f)). The
same damage is not present in the sonications with calcifications at further
distances (i.e, 10 mm and above), which indicates that calcifications located
very close to the transducer might cause thermal damage to the urethra.
21
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Figure 7: The dependence of 240 CEM thermal dose area upon (a) the diameter of the
calcification, (b) the distance of the calcification centre from the transducer, (c) sonication
duration and (d) sonication frequency. (e)-(h) Contour lines showing the boundaries of
the same thermal dose areas on an axial plane crossing the centre of the transducer,
respectively. The sonication duration was 20 seconds followed by a 40-second cooling time
in all cases except for (c) and (g) where the sonication duration was varied.
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The dependence of thermal dose area upon the sonication duration with
fixed calcification diameter (5 mm) and location from the transducer (10 mm)
is shown in Figure 7(c). The axial planes of the same areas are shown with
contours in Figure 7(g). The thermal dose area grows with sonication du-
ration, but the growth rate slows slightly with longer sonication durations.
The axial contours show that the treated region behind the calcification grows
slightly with sonication duration, but the growth speed is still slower than
the region boundary without an obstructing calcification. This indicates
that simply increasing the sonication duration in order to ablate the region
behind the calcifications is not feasible since this could cause damage to
adjacent healthy tissue regions. It can also be seen that with a 10-second
sonication duration, the damaged tissue region behind the calcification ac-
tually extends further than it otherwise would without the calcification in
place. This is caused by the dissipation of heat energy from the calcification
to the surrounding tissue regions due to its high thermal conductivity.
Another method to treat the tissue regions behind the calcifications could
possibly be the usage of lower ultrasound frequencies due to the lower at-
tenuation, and hence, higher penetration depth. Figure 7(d) illustrates the
dependence of thermal dose area upon sonication frequency for a fixed cal-
cification diameter (5 mm) and distance from the transducer (10 mm). The
axial contour profiles of the same areas are shown in Figure 7(h). The ther-
mal dose areas grow with sonication frequency up to 3 MHz after which the
area becomes smaller again. This is an interesting observation because the
heating rate is directly dependent on frequency, and therefore, one would
expect the area to grow with higher frequencies. However, higher frequencies
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are also more strongly attenuated in the tissue. Thus, higher frequencies can
be seen to heat more in the near field while lower frequencies extend further.
When using a frequency of 1 MHz, the 20-second sonication duration was
not long enough to cause any thermal damage above 240 CEM. The hypoth-
esis of better penetration of ultrasound to the region behind the calcification
with lower frequencies also does not hold true: the untreated regions be-
hind the calcification between 2, 3 and 4 MHz frequencies have almost the
same depth. This is due to the fact that large acoustic impedance mismatch
still exists between the prostate and the calcification although the effect of
attenuation is smaller with lower frequencies.
The axial temperature profiles along the central axis of the transducer
at the end of the 20-second sonication are shown in Figure 8 for all the
cases described above. Figure 8(a) shows the axial temperature profiles with
different calcification diameters located 10 mm from the transducer. The
temperature profile without the calcification is also shown for reference. In
all cases, the temperature sharply increases towards the calcification and
peaks at around 5 mm. Slightly higher temperatures in the proximity of
the transducer are seen when calcifications are present. After the peak, an
almost linear temperature decrease is seen inside the calcification as the heat
energy dissipates from the front of the calcification towards the cooler rear
side and further into the prostate tissue. When again entering to the region
of the prostate tissue, a sharper drop in the temperature is seen. This is most
likely caused by perfusion carrying the heat energy away, which is not the
case inside the calcification. The region behind the calcification also stays
cooler due to smaller heating rate of the ultrasound field.
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Figure 8: Axial temperature profiles from the centre of the transducer (the origin) along
the y-axis with (a) a spherical calcification with different diameters with the centre located
at 10 mm distance from the transducer, (b) a spherical calcification with a fixed 5 mm
diameter with the centre located at different distances from the transducer, (c)-(d) a
spherical calcification with a fixed diameter (5 mm) and distance (10 mm) from the centre
of the transducer with different sonication durations and frequencies, respectively. A
simulation without a calcification (4 MHz, 20 s) is also shown in each figure for reference.
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Figure 8(b) shows the axial temperature profiles with a fixed diameter
(5 mm) calcification located at different distances from the transducer. As
the calcification is moved further away from the transducer, the location
of the linear temperature decrease and the sharper temperature drops also
shift. When the calcification is very close to the transducer, the increase
in temperature in the beginning is more rapid, which indicates some of the
heat energy is accumulating between the transducer and the calcification
despite of the constant temperature ultrasound probe acting as a heat sink.
During the clinical treatments, this could possibly cause thermal damage to
the urethra.
Figure 8(c) shows the axial temperature profiles with different sonication
durations while the diameter (5 mm) and the position (10 mm) of the calci-
fication was kept constant. The trends are similar to previous figures where
linear temperature decreases are seen inside the calcifications followed by a
steeper drop when entering the region of the prostate at y = 12.5 mm. The
longer the sonication duration, the higher the temperature elevation both in
front of and behind the calcifications. The temperature curves also seem to
peak right in front of the calcifications.
Finally, the effect of different sonication frequencies on the axial tem-
perature profiles with a fixed calcification diameter (5 mm) and location
(10 mm) is shown in Figure 8(d). Since the heating rate is dependent on the
frequency, sonications with higher frequencies exhibit higher temperatures
when the sonication duration and power are kept constant. Again, similar
characteristics are seen in the profiles as observed before with a linear de-
crease in temperature inside the calcification and a more pronounced drop
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in temperature when entering the prostate tissue from the rear side of the
calcification. The temperatures behind the calcification are not much larger
with higher frequencies, which further indicates that they cannot penetrate
effectively through the interfaces of high acoustic impedance mismatch.
Sonication strategies
Encouraged by the results from the sonications with artificial calcifica-
tions, different sonication strategies were tested on naturally occurring cal-
cifications in different patients. The results from the artificial study showed
that the best strategy is to vary the sonication duration in order to ablate
the tissue regions behind the calcifications.
Figure 9 shows the execution of a 20+40-second sonication strategy in
patient 2. In this approach, a 20-second therapeutic sonication with all ele-
ments active was followed by a 40-second sonication using only the element(s)
in front of the calcification(s) active (in this case, a single element). In Fig-
ure 9(b) it can be seen that the calcification effectively blocks the ultrasound
field from penetrating to the rear region. The resulting temperature distri-
bution at the end of the sonication is also shown in Figure 9(c). It is evident
that the strongest heating is in front of the calcification from where it is
conducted to the rear side and further into the prostate tissue.
Figures 10(a)-(c) show the boundaries of the thermal dose areas resulting
from different sonication strategies in patients 1-3, respectively. In each case,
different sonication strategies were tested in order to treat the tissue region
behind the calcifications. The maximum temperature reached during the
strategy sonications was 93.9 ◦C, which is still below the boiling temperature.
Figure 10(a) shows the contours of the thermal dose areas on an axial
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plane cutting through the centre of the transducer in patient 1. In this case,
there are multiple calcifications at different locations in the prostate. Con-
ducting a 20-second therapeutic sonication leaves noticeable untreated areas
behind the calcifications when compared to the same sonication without the
calcifications. The 20+20-second strategy sonication shows the boundaries
after a full 20-second therapeutic sonication with all the elements active fol-
lowed by a 20-second sonication using only the elements 3, 8 and 9 (from
right to left). The sonication strategy successfully ablates the regions behind
the calcifications. However, some additional damage is also present beyond
the boundary of the original sonication. This was because elements 8-9 partly
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Figure 9: The execution of a 20+40-second sonication strategy in patient 2. (a) A 20-
second sonication with all the elements followed by (b) a 40-second sonication using the
single element in front of the calcification. (c) Temperature map at the end of the 20+40-
second sonication shows the distribution of heat around the calcification.
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overlap the edges of the calcification, and thus were able to penetrate deeper
into the prostate.
Figure 10(b) shows the thermal dose boundaries in patient 2 with dif-
ferent sonication strategies. After a 20-second sonication with all elements
active followed by a 40-second cooling time, the calcification has left a large
untreated region behind. When the 20-second sonication was followed by
a 20-second sonication with a single element (i.e., 20+20 s) the untreated
region is greatly reduced (approximately by 50%). When the sonication du-
ration with a single element was further increased to 40 seconds, the region
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Figure 10: (a)-(c) The boundaries of 240 cumulative equivalent minutes (CEM) thermal
dose areas on the axial plane cutting through the centre of the transducer in patients
1-3, respectively. Therapeutic 20-second sonications were conducted with and without
the calcifications in addition to different sonication strategies. The selective elements are
highlighted in red.
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boundary covers almost the same extent as the therapeutic sonication with-
out the calcification. However, caution has to be taken in the region between
the calcification and the transducer, where some thermal damage has also
occurred.
Figure 10(c) shows the thermal dose boundaries in patient 3. In this
case, the calcification was located at the edge of the prostate right in front of
the first transducer element. After a 20-second therapeutic sonication, the
treated region at the boundary had narrowed compared to the sonication
without the calcification. When the 20-second sonication was followed by a
20-second or 30-second sonications using only the first element, the treated
region is increased. Some thermal damage also extended outside the prostate
in the lateral (x) direction, which is not visible in the sonication without the
calcification.
Discussion
The purpose of this study was to investigate clinical questions regarding
the therapeutic ultrasound treatment of the prostate. In particular: What
is the maximum size of prostatic calcification that does not limit the treat-
ment region? What is the minimum distance of the calcification from the
transducer so that no thermal damage is induced in the urethra? What is
the best strategy to treat the tissue region behind the calcification? In order
to answer these question, realistic computational simulations were conducted
using clinical patient data. The simulations were carried out with both nat-
urally occurring and artificial calcifications whose sizes and locations were
varied.
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Regarding the maximum size of the calcification, the answer is somewhat
expected: it depends. Even with a 1 mm diameter calcification, a small ‘dint’
was seen at the outer boundary of the thermal dose area. Whether the size
of this untreated region is clinically significant or not is another question.
As the size of the calcification increased, the area of the untreated region
behind the calcification grew to a certain point. However, when the size of
the calcification increased sufficiently (7 mm and above), the treated region
behind the calcification started growing again. This happened due to the
fact that the thermal conductivity of the calcifications is relatively high, and
therefore, some of the heat energy in front and inside the calcification was
dissipated to the tissue regions surrounding the calcification. To conclude,
even calcifications smaller than 10 mm in diameter can cause large untreated
tissue regions if they are located close to the transducer. The maximum size
of the calcification used in this study was 10 mm in diameter, but also larger
occurrences are possible (Hong et al., 2012).
Another factor affecting the size of the untreated region behind the calcifi-
cation is the distance of the calcification from the transducer. As the distance
from the transducer becomes larger, the untreated region becomes smaller.
At large distances, the treatment region actually expands beyond what it
would be without the calcification due to thermal conductivity. Therefore,
it is advisable to avoid heating calcifications which are located very close to
critical structures such as the urethra, bladder neck or rectal wall.
The minimum distance at which the calcification can be located from the
transducer before any thermal damage is induced in the urethra is dependent
on the sonication duration and the efficiency of the heat sink, which in this
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case was the constant temperature ultrasound probe. In the simulations, the
closest distance of the surface of the calcification from the transducer was
2.5 mm, which is only 0.5 mm away from the ultrasound probe (there exists
a 2 mm layer of water between the transducer and the sonication window).
At this distance, slight thermal damage (approximately 0.5 mm) extended
from the calcification towards the transducer during the 20-second sonication.
Only when the distance was increased to 7.5 mm, no thermal damage in the
urethra was observed. Thus, heat accumulation can be expected to occur
between the transducer and the calcification, which could potentially cause
thermal damage to the urethra if the cooling is not sufficient. Therefore,
a margin of at least 7.5 mm between the transducer and the calcification
should be left in order to avoid additional thermal damage to the urethra.
With regards to the best sonication strategy to treat the tissue regions
behind calcifications, two different approaches can be taken: lowering the
sonication frequency or increasing the sonication duration. The former ap-
proach is based on the assumption that lower frequency ultrasound waves
could potentially penetrate through calcifications with smaller energy loss
due to the lower attenuation. However, it was observed that the bound-
ary of the untreated region behind the calcification remained approximately
the same when the sonication frequency was changed between 1 and 4 MHz
while keeping the sonication duration constant. This occurred despite the
fact that higher frequencies exhibit higher heating rate when the power level
is kept constant. This suggests that a better strategy might be using longer
sonication durations.
Longer sonication durations were seen to extend the boundary of the
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treated region behind the calcification, but at a lower pace than in the regions
where there were no calcifications. Therefore, a better strategy would be to
first treat the desired tissue regions and then only focus on the remaining
untreated region behind the calcification. In this case, the elements directly
in front of the calcifications were selected to treat the remaining untreated
tissue regions behind.
The simulation results for calcifications in this study are in agreement
with previous research studying ultrasound beam distortion due to fiducial
markers during transrectal focused ultrasound therapy in the prostate (Geor-
giou et al., 2017; Bakaric et al., 2018). It was found that the beam distortion
due to the markers may result in an untreated region beyond the marker
due to reflections. Although the acoustic properties of gold fiducial markers
are different to those of the prostatic calcifications, they both act as strong
acoustic reflectors.
Temperature mapping during treatments is usually performed using pro-
ton resonance frequency shift based MRI thermometry. Unfortunately, this
technique is prone to susceptibility effects that cause a signal void in tempera-
ture maps. In addition, these techniques can be very sensitive to temperature-
induced tissue susceptibility changes (Sprinkhuizen et al., 2010). There could
be even false temperature readings in the immediate vicinity of calcifications.
The severity of this problem is likely to depend on the size of calcification,
but it can cause an additional challenge when validating the results of these
simulations by phantom experiments or during actual treatments. On the
other hand, it underlines the importance of simulation studies in order to
estimate the temperature distribution around calcifications.
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The simulation models used in this study were realistic taking into ac-
count all the relevant acoustic and thermal effects such as nonlinearity and
perfusion. The phenomenon not taken into account that could possibly be
induced by the presence of calcifications in the ultrasound field is the acous-
tic cavitation (Coussios et al., 2007). The strong acoustic reflections caused
by the calcifications create a large negative pressure in front of the calcifica-
tion, which could potentially trigger cavitation in the same location. In the
simulations, the maximum mechanical index (MI) in front of the calcifica-
tions was 1.0 which is well below the Food and Drug Administration (FDA)
recommended limit of 1.9 for diagnostic ultrasound devices (Szabo, 2004).
Therefore, it is unlikely that cavitation would cause any tissue destruction
in the region in front of the calcification.
Conclusions
The aim of this study was to examine how prostatic calcifications of differ-
ent sizes and locations affect the efficacy of transurethral ultrasound therapy
in the prostate. It was found that for fixed sonication parameters, even small
calcifications leave untreated regions behind them due to strong acoustic re-
flections and high attenuation. Furthermore, increased temperature elevation
between the calcification and the transducer was seen.
In addition, different sonication strategies were tested in order to deliver
therapy to the untreated regions behind the calcifications. The best strategy
was to conduct prolonged sonications using the elements directly in front
of the calcifications. This way the heat energy was conducted through the
calcification to the surrounding tissue regions. However, attention should
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be paid to avoid calcifications located close to sensitive tissues such as the
urethra, bladder neck or rectal wall.
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